A new way of defining clinical endpoints with Sébastien Coppe

Join host Sylvain Berthelot and Sébastien Coppe, CEO and co-founder of One2Treat, to explore a patient-focused approach to redefining clinical endpoints. Drawing from his background in optimizing clinical supply chains and his passion for involving patients more deeply in trial design, Sébastien shares how One2Treat is using technology to bring the patient’s voice into the earliest stages of clinical development.

The discussion touches on the limitations of traditional endpoints, the value of co-designing studies with patients, and the promise of tools that capture lived experiences to define outcomes that truly matter. Sébastien emphasizes the need to rethink how we measure success in trials, through real-world impact and patient relevance.

Tune in to discover how new statistical approaches are enabling a more meaningful way to define what good looks like in clinical research.

Share via

See CRScube in action

Book a demo

Explore how our platform will elevate your team and clinical trial management.

Get insights straight to your inbox

Explore our knowledge base

Stay in-the-know with regular updates and industry opinions from our expert team.

See all resources

Featured resources

Modern safety reporting in a legacy world – How cubeSAFETY compares, according to CRScube’s COO

Safety reporting is moving beyond simple adverse event collection. The future lies in intelligent risk detection and frictionless data capture.

Electronic safety reporting in clinical trials: What sponsors need to know

For sponsors and CROs, it is crucial to understand the implications of the full enforcement of ICH E2B(R3) standards, especially as it impacts both pre- and post-authorization submissions.